Prostate cancer has a rich trial landscape. From PARP inhibitors for BRCA-mutated cases to lutetium PSMA, here's what's recruiting in 2025.
About this article: Educational and informational only. Does not constitute medical advice or eligibility guidance. Always discuss clinical trial options with your care team. Verify current trial status at ClinicalTrials.gov.
What You Need to Know
What prostate cancer clinical trials are recruiting in 2025 — from mCRPC studies to localized disease, PARP inhibitors, radiopharmaceuticals, and immunotherapy combinations.
Find recruiting trials for your condition
Search ClinicalTrials.gov in real time — matched to your profile, explained in plain English. Free, no account required.
Start Free Search →How Tidera Health Can Help
Tidera Health searches ClinicalTrials.gov in real time and uses AI to explain which trials may be relevant to your condition, age, location, and treatment history. It's free, requires no account, and stores no health data.
Enter your condition and location to see currently recruiting trials matched to your profile — with plain-English eligibility explanations and questions to ask the research coordinator.